American Journal of Obstetrics & Gynecology
Volume 203, Issue 1 , Pages 32.e1-32.e8, July 2010

Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid

Presented in part at the 25th Annual Meeting of the Society for Maternal-Fetal Medicine, San Francisco, CA, Feb. 5-10, 2007.

  • Jane Hitti, MD

      Affiliations

    • Department of Obstetrics/Gynecology, University of Washington, Seattle, WA
  • ,
  • Jodi A. Lapidus, PhD

      Affiliations

    • Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland, OR
    • ProteoGenix Inc., Beaverton, OR
  • ,
  • Xinfang Lu, MS

      Affiliations

    • ProteoGenix Inc., Beaverton, OR
  • ,
  • Ashok P. Reddy, PhD

      Affiliations

    • ProteoGenix Inc., Beaverton, OR
  • ,
  • Thomas Jacob, PhD

      Affiliations

    • ProteoGenix Inc., Beaverton, OR
  • ,
  • Surendra Dasari, PhD

      Affiliations

    • ProteoGenix Inc., Beaverton, OR
  • ,
  • David A. Eschenbach, MD

      Affiliations

    • Department of Obstetrics/Gynecology, University of Washington, Seattle, WA
  • ,
  • Michael G. Gravett, MD

      Affiliations

    • Department of Obstetrics/Gynecology, University of Washington, Seattle, WA
    • ProteoGenix Inc., Beaverton, OR
  • ,
  • Srinivasa R. Nagalla, MD

      Affiliations

    • Department of Pediatrics, Oregon Health & Science University, Portland, OR
    • ProteoGenix Inc., Beaverton, OR

Received 17 September 2009; received in revised form 15 January 2010; accepted 18 March 2010. published online 17 May 2010.

Objective

We analyzed the vaginal fluid proteome to identify biomarkers of intraamniotic infection among women in preterm labor.

Study Design

Proteome analysis was performed on vaginal fluid specimens from women with preterm labor, using multidimensional liquid chromatography, tandem mass spectrometry, and label-free quantification. Enzyme immunoassays were used to quantify candidate proteins. Classification accuracy for intraamniotic infection (positive amniotic fluid bacterial culture and/or interleukin-6 >2 ng/mL) was evaluated using receiver-operator characteristic curves obtained by logistic regression.

Results

Of 170 subjects, 30 (18%) had intraamniotic infection. Vaginal fluid proteome analysis revealed 338 unique proteins. Label-free quantification identified 15 proteins differentially expressed in intraamniotic infection, including acute-phase reactants, immune modulators, high-abundance amniotic fluid proteins and extracellular matrix–signaling factors; these findings were confirmed by enzyme immunoassay. A multi-analyte algorithm showed accurate classification of intraamniotic infection.

Conclusion

Vaginal fluid proteome analyses identified proteins capable of discriminating between patients with and without intraamniotic infection.

Key words: intraamniotic infection, preterm labor, proteomics, vaginal fluid

 

 Supported by National Institutes of Health Grant no. AI31871. These analyses were supported by ProteoGenix, Inc.

 Oregon Health & Science University and Drs Gravett, Nagalla, and Lapidus have a significant financial interest in ProteoGenix, Inc, which is a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed, and a management plan has been approved by the Oregon Health & Science University Integrity Program Oversight Council and by the University of Washington Office of Technology Transfer. ProteoGenix provided the technical assays and proteomic analysis. Article preparation and submission was independent of the sponsor.

 Reprints not available from the authors.

 Cite this article as: Hitti J, Lapidus JA, Lu X, et al. Noninvasive diagnosis of intraamniotic infection: proteomic biomarkers in vaginal fluid. Am J Obstet Gynecol 2010;203:32.e1-8.

PII: S0002-9378(10)00356-X

doi:10.1016/j.ajog.2010.03.037

American Journal of Obstetrics & Gynecology
Volume 203, Issue 1 , Pages 32.e1-32.e8, July 2010